Research output per year
Research output per year
Research output
Search results
-
2016
Angiotensinogen and HLA Class II Predict Bevacizumab Response in Recurrent Glioblastoma Patients
Urup, T., Michaelsen, S. R., Olsen, L. R., Toft, A., Christensen, I. J., Grunnet, K., Winther, O., Broholm, H., Kosteljanetz, M., Issazadeh-Navikas, S., Poulsen, H. S. & Lassen, U., 2016.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
Effects of bevacizumab combination therapy on transcriptional changes in responding and non-responding recurrent glioblastoma patients
Urup, T., Michaelsen, S. R., Staunstrup, L. M., Vitting-Seerup, K., Bennedbæk, M., Toft, A., Jønson, L., Broholm, H., Hamerlik, P., Poulsen, H. S. & Lassen, U., 2016.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
Prognostic and Predictive Biomarkers in Recurrent WHO Grade 3 Glioma Patients Treated with Bevacizumab and Irinotecan
Toft, A., Urup, T., Christensen, I. J., Michaelsen, S. R., Singh, L. B., Grunnet, K., Kosteljanetz, M., Larsen, A. V. A., Broholm, H., Lassen, U. & Poulsen, H. S., 2016.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
Quantitative and allelic methylation analyses of MGMT in gliobastoma
Kristensen, L. S., Michaelsen, S. R., Dyrbye, H., Aslan, D., Grunnet, K., Christensen, I. J., Poulsen, H. S., Grønbæk, K. & Broholm, H., 2016.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
VEGF-C contributes to autocrine VEGF Receptor 2 signaling and cellular maintenance in glioblastoma
Michaelsen, S. R., Nedergaard, M. K., Broholm, H., Bartkova, J., Staberg, M., Urup, T., Aghi, M., Lucacova, S., Villingshøj, M., Pedersen, P., Kjær, A., Perryman, L., Erler, J. T., Bartek, J., Lassen, U., Stockhausen, M., Poulsen, H. S. & Hamerlik, P., 2016.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
2015
EPID-28. PROGNOSTIC AND PREDICTIVE BIOMARKERS IN RECURRENT WHO GRADE 3 GLIOMA PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN
Toft, A., Urup, T., Grunnet, K., Christensen, I. J., Michaelsen, S. R., Broholm, H., Singh, L. B., Larsen, V. A., Kosteljanetz, M., Lassen, U. & Poulsen, H. S., 2015.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review